EUVIMEDObjevte EUVIMED
Multizentrische StudieOpen access · CC BY 4.0

Quality of life changes in cluster headache: Convergent validity, responsiveness, and interpretability of the Cluster Headache Quality of Life scale as a patient‐reported outcome measure

Willemijn C Naber iD, Paulien J van Tilborg iD, Roemer B Brandt iD, Julia J Jansen, Leopoldine A Wilbrink, Wim M Mulleners, Erkan Kurt, Willemijn Leen, Frank J P M Huygen, Denise Bijlenga, Rolf Fronczek iD

Headache: The Journal of Head and Face Pain · 2026

DOI: 10.1111/head.15083 ↗

At a glance

Multizentrische Studie in Headache: The Journal of Head and Face Pain, 2026. Written by Willemijn C Naber and 10 co-authors. Institution: Department of Neurology, Leiden University Medical Center (LUMC), Leiden, The Netherlands. Major MEDLINE topics: Cluster Headache, Patient Reported Outcome Measures, Psychometrics, Quality of Life. Cited 2 times so far (Crossref); 25 references. The full text is freely available (open access, CC BY 4.0). Funded by: ZonMw.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

Cluster headache (CH) significantly impacts patients' quality of life (QoL). We aim to validate the Cluster Headache Quality of Life scale (CHQ) for measuring QoL changes in patients with CH.

Methods

In this multicenter, prospective, longitudinal psychometric validation study, participants, all with chronic CH (CCH), completed the CHQ at a 3‐monthly interval alongside headache diaries and general QoL questionnaires (36‐item Short Form [SF‐36], Hospital Anxiety and Depression Scale [HADS], and EuroQol 5 Dimensions [EQ‐5D]). CHQ's ability to measure changes was validated in three steps following COSMIN guidelines: (1) convergent validity, (2) responsiveness, and (3) interpretability. Baseline scores were used for step 1; change scores for steps 2 and 3 (Δ baseline—follow‐up). Twelve correlation hypotheses were formulated and tested for steps 1 and 2. Validity was rated by % rejected hypotheses (high: ≤25%, moderate: 26%–50%, poor: ≥50%). Data were collected in the Netherlands (Leiden, Nijmegen, Heerlen) between 9 December 2021 and 18 November 2024.

Results

For step 1, 117 participants were included ( n = 70 for SF‐36/HADS analyses, n = 42 for EQ‐5D analyses) and 82 were included for steps 2 and 3 ( n = 48 for SF‐36/HADS analyses, n = 29 for EQ‐5D analyses). At baseline, overall QoL was poor (CHQ: 60.9 ± 23.1, SF‐36: 46.7 ± 19.9) and worse in participants with more intense and frequent CH attacks (>CHQ scores: β = 2.92 (95% confidence interval [CI] 0.91 to 4.93), p = 0.005; β = 0.27 (95% CI 0.02 to 0.53), p = 0.033). Convergent and responsiveness validity was high (≤25% hypotheses rejected). CHQ baseline scores correlated strongly with the HADS, SF‐36, and EQ‐5D ( ρ = 0.68, ρ = −0.60, ρ = −0.52), but weakly with attack frequency ( ρ = 0.27). Change scores correlated strongly with HADS and SF‐36 ( ρ = 0.51, ρ = −0.56) and moderately with EQ‐5D ( ρ = −0.38). Step 3 indicated ≤ −3.5 points change as clinically relevant improvement and ≥7.5 points as deterioration.

Conclusion

The CHQ has a high validity to measure change in QoL. CH attack frequency influences QoL, but QoL is more strongly correlated with mental health and activity restrictions than attack frequency. Implementing the CHQ may improve understanding of disease burden, enabling more targeted treatment strategies and thus improving overall disease management.

Subjects

MeSH terms (MEDLINE)

Cluster HeadachePatient Reported Outcome MeasuresPsychometricsQuality of LifeAdultFemaleHumansMaleMiddle AgedLongitudinal StudiesProspective StudiesReproducibility of Results

Author keywords

Cluster Headache Quality of Life scalecluster headachepatient‐reported outcome measurequality of life

Authors and institutions

  • Department of Neurology, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
  • Department of Neurology, The Migraine Clinic, Amsterdam, The Netherlands.
  • Department of Neurology, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands.
  • Department of Pharmacy, Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Neurology, Zuyderland Medical Center, Heerlen, The Netherlands.
  • Department of Neurosurgery, Radboud University Medical Center, Nijmegen, The Netherlands.

ORCID profiles: Willemijn C Naber, Paulien J van Tilborg, Roemer B Brandt, Rolf Fronczek

Funding

  • ZonMw

Cite

APA

Naber, W. C., van Tilborg, P. J., Brandt, R. B., Jansen, J. J., Wilbrink, L. A., Mulleners, W. M., Kurt, E., Leen, W., Huygen, F. J. P. M., Bijlenga, D., & Fronczek, R. (2026). Quality of life changes in cluster headache: Convergent validity, responsiveness, and interpretability of the Cluster Headache Quality of Life scale as a patient‐reported outcome measure. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.15083

Vancouver

Naber WC, van Tilborg PJ, Brandt RB, Jansen JJ, Wilbrink LA, Mulleners WM, et al. Quality of life changes in cluster headache: Convergent validity, responsiveness, and interpretability of the Cluster Headache Quality of Life scale as a patient‐reported outcome measure. Headache: The Journal of Head and Face Pain. 2026. doi:10.1111/head.15083

BibTeX
@article{Naber2026,
  author = {Naber, Willemijn C and van Tilborg, Paulien J and Brandt, Roemer B and Jansen, Julia J and Wilbrink, Leopoldine A and Mulleners, Wim M and Kurt, Erkan and Leen, Willemijn and Huygen, Frank J P M and Bijlenga, Denise and Fronczek, Rolf},
  title = {Quality of life changes in cluster headache: Convergent validity, responsiveness, and interpretability of the Cluster Headache Quality of Life scale as a patient‐reported outcome measure},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2026},
  doi = {10.1111/head.15083}
}
Start for free →